Sonova (SONVY) Stock Price, News & Analysis

Company Overview

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems. Beyond core devices, the company offers complementary products such as remote microphones, streamers and mobile apps that support sound personalization and remote care. Sonova supports its product offerings through a network of distribution channels, hearing care specialists and branded retail operations, providing clinical fitting, follow-up care and rehabilitation services.

Operating globally, Sonova serves patients and professional customers across Europe, North America, Asia‑Pacific, Latin America and other regions, emphasizing research and development to advance audiological technology. The company works with hearing care professionals and clinical partners to deliver integrated solutions that combine devices, software and services intended to improve speech understanding and everyday communication for people with hearing impairment.

Key Stats

• Today's Range: $43.72 to $44.65
• 50-Day Range: $42.90 to $52.17
• 52-Week Range: $42.26 to $68.76
• Volume: 43,176 shs
• Average Volume: 40,668 shs
• Market Capitalization: $13.26 billion
• P/E Ratio: N/A
• Dividend Yield: 1.42%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Sonova Stock Analysis - MarketRank™

Sonova scored higher than 50% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Sonova has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 strong buy ratings, 1 buy rating, 4 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Sonova has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.60%

Earnings Growth

Earnings for Sonova are expected to grow by 9.60% in the coming year, from $2.50 to $2.74 per share.

Price to Earnings Growth Ratio

Sonova has a PEG Ratio of 3.29. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Sonova has a P/B Ratio of 4.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Sonova has been sold short.

Short Interest Ratio / Days to Cover

Sonova has a short interest ratio ("days to cover") of 0.03, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sonova has recently decreased by 20.95%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Sonova pays a meaningful dividend of 1.42%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sonova does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Sonova will have a dividend payout ratio of 22.99% next year. This indicates that Sonova will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.43

News Sentiment

Sonova has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sonova this week, compared to 1 article on an average week.

MarketBeat Follows

Only 1 people have added Sonova to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sonova insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.01% of the stock of Sonova is held by insiders.

Percentage Held by Institutions

0.01% of the stock of Sonova is held by institutions.

SONVY Stock Analysis - Frequently Asked Questions

How have SONVY shares performed this year?

Sonova's stock was trading at $51.8310 at the beginning of 2026. Since then, SONVY stock has decreased by 14.2% and is now trading at $44.4810.

How do I buy shares of Sonova?

Shares of SONVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/05/2026
• Next Earnings (Estimated): 5/07/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SONVY
• CIK: 1450681
• Web: www.sonova.com
• Phone: (158) 928-0101
• Fax: 41-58-928-2011
• Employees: 17,990
• Year Founded: 1947

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 17.79
• P/E Growth: 3.29
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.51
• Current Ratio: 1.24
• Quick Ratio: 0.91

Sales & Book Value

• Annual Sales: $4.36 billion
• Price / Sales: 3.04
• Cash Flow: $3.43 per share
• Price / Cash Flow: 12.97
• Book Value: $10.16 per share
• Price / Book: 4.38

Miscellaneous

• Outstanding Shares: 298,040,000
• Free Float: 298,010,000
• Market Cap: $13.26 billion
• Optionable: Not Optionable
• Beta: 1.26